DarioHealth (NASDAQ:DRIO) Share Price Crosses Below 200-Day Moving Average – Here’s What Happened

DarioHealth Corp. (NASDAQ:DRIO)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.15 and traded as low as $0.86. DarioHealth shares last traded at $0.87, with a volume of 33,990 shares traded.

DarioHealth Stock Performance

The firm has a market cap of $27.09 million, a PE ratio of -0.92 and a beta of 1.51. The company has a 50 day simple moving average of $0.95 and a 200-day simple moving average of $1.15. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.26 and a quick ratio of 1.96.

Hedge Funds Weigh In On DarioHealth

An institutional investor recently raised its position in DarioHealth stock. Appian Way Asset Management LP increased its stake in DarioHealth Corp. (NASDAQ:DRIO) by 3.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,375,880 shares of the company’s stock after acquiring an additional 41,738 shares during the period. Appian Way Asset Management LP owned about 4.60% of DarioHealth worth $1,637,000 as of its most recent SEC filing. 33.39% of the stock is owned by hedge funds and other institutional investors.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.